Sensorion Logo

Sensorion

Clinical-stage biotech developing novel therapies for inner ear disorders and hearing loss.

ALSEN | PA

Overview

Corporate Details

ISIN(s):
FR0012596468 (+2 more)
LEI:
969500P0W8XJ9CGZDP97
Country:
France
Address:
375 RUE DU PROFESSEUR BLAYAC, 34080 MONTPELLIER

Description

Sensorion is a clinical-stage biotechnology company specializing in the development of novel therapies for inner ear disorders. The company's mission is to address the significant unmet medical need of hearing loss by creating innovative therapeutic solutions. Its strategy is built on three pillars: restoring hearing through gene therapies for genetic diseases, treating existing hearing disorders with small molecule therapeutics, and preventing non-genetic hearing loss, such as drug-induced ototoxicity. Sensorion utilizes a unique R&D technology platform to advance its understanding of the pathophysiology of inner ear diseases and develop its pipeline of clinical candidates.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-17 07:30
Inside Information / News release on accounts, results
English 253.3 KB
2025-09-17 07:30
Informations privilégiées / Communiqué sur comptes, résultats
French 273.6 KB
2025-09-04 07:30
Inside Information / Other news releases
English 168.5 KB
2025-09-04 07:30
Informations privilégiées / Autres communiqués
French 174.1 KB
2025-08-15 07:30
Inside Information / Other news releases
English 139.2 KB
2025-08-15 07:30
Informations privilégiées / Autres communiqués
French 140.2 KB
2025-07-29 07:30
Inside Information / Other news releases
English 188.2 KB
2025-07-29 07:30
Informations privilégiées / Autres communiqués
French 192.0 KB
2025-07-01 07:30
Inside Information / Other news releases
English 187.9 KB
2025-07-01 07:30
Informations privilégiées / Autres communiqués
French 194.8 KB
2025-05-13 07:30
Informations privilégiées / Autres communiqués
French 133.2 KB
2025-05-13 07:30
Inside Information / Other news releases
English 139.4 KB
2025-05-06 07:30
Inside Information / Other news releases
English 180.6 KB
2025-05-06 07:30
Informations privilégiées / Autres communiqués
French 176.8 KB
2025-04-25 07:30
Inside Information / Other news releases
English 151.9 KB

Automate Your Workflow. Get a real-time feed of all Sensorion filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Sensorion

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Sensorion via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-04-11 N/A Other Other 2,781,914 1,752,605.82 EUR
2024-04-11 N/A Other Other 1,587,301 999,999.63 EUR
2024-02-13 N/A Other Other 16,842,105 9,599,999.85 EUR
2024-02-08 N/A Other Other 12,280,701 6,999,999.57 EUR
2023-08-08 N/A Other Other 46,428,571 12,999,999.88 EUR
2023-08-03 N/A Other Other 25,000,000 7,000,000.00 EUR

Peer Companies

Isofol Medical Logo
Clinical-stage biotech developing a folate-based therapy to enhance cancer treatments.
Sweden
ISOFOL
IVIM Technology, Inc. Logo
Provides intravital microscopy systems and CRO services for biomedical research.
South Korea
460470
IXICO PLC Logo
Provides AI-driven neuroimaging and data analytics for neuroscience clinical trials.
United Kingdom
IXI
Jade Biosciences, Inc. Logo
A clinical-stage biotech developing therapies for autoimmune and inflammatory diseases.
United States of America
JBIO
Jasper Therapeutics, Inc. Logo
A clinical-stage biotech developing therapies targeting mast and hematopoietic stem cells.
United States of America
JSPR
J. Molner AS Logo
A CDRO developing generic sterile injectable and dermatological dosage forms.
Estonia
JML
Kadimastem Ltd. Logo
Clinical-stage cell therapy company developing treatments for ALS and diabetes.
Israel
KDST
KAINOS MEDICINE, INC. Logo
Develops small molecule therapeutics for neurodegenerative, infectious, and oncological diseases.
South Korea
284620
Kairos Pharma, LTD. Logo
Develops oncology therapies targeting drug resistance and immune suppression.
United States of America
KAPA
Kancera Logo
Pharmaceutical company seeking a reverse takeover to leverage its public listing.
Sweden
KAN

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.